Related Experiment Videos
Pathogenesis of Recurrent Vulvovaginal Candidiasis
1Division of Infectious Diseases, Harper University Hospital, 3990 John R - Room 4811, Detroit, MI 48201, USA. jsobel@intmed.wayne.edu
Current Infectious Disease Reports
|November 16, 2002
Summary
Recurrent vulvovaginal candidiasis (RVVC) presents significant challenges. Many cases lack identifiable causes, suggesting an immune system role in this common condition.
Area of Science:
- Gynecology
- Infectious Diseases
- Immunology
Background:
- Recurrent vulvovaginal candidiasis (RVVC) is a prevalent condition causing significant patient distress and posing therapeutic difficulties.
- The etiology of RVVC is multifactorial, necessitating comprehensive management strategies that address complex causative pathways.
- While progress has been made in identifying secondary causes, including biologic and host factors, a substantial portion of RVVC cases remain unexplained.
Purpose of the Study:
- To explore the multifactorial etiology of recurrent vulvovaginal candidiasis (RVVC).
- To investigate potential host and microbial factors contributing to RVVC.
- To generate hypotheses regarding the role of the immune system in RVVC pathogenesis.
Main Methods:
- Review of existing literature on RVVC etiology.
- Analysis of microbiologic data regarding Candida species and azole resistance.
- Evaluation of identified host and microbial predisposing factors.
Main Results:
- Azole resistance in Candida albicans is infrequent.
- Infection by non-albicans Candida species with reduced sensitivity is uncommon.
- At least 50% of women with RVVC lack identifiable predisposing host or microbial factors.
Conclusions:
- The multifactorial nature of RVVC requires consideration of complex etiologic pathways.
- Identified microbial factors like azole resistance are not the primary drivers in most RVVC cases.
- The high prevalence of unexplained cases supports an immune-based hypothesis for RVVC pathogenesis.